Frontiers in Oncology (Mar 2022)

MicroRNA-138 Abates Fibroblast Motility With Effect on Invasion of Adjacent Cancer Cells

  • Saroj Rajthala,
  • Saroj Rajthala,
  • Himalaya Parajuli,
  • Himalaya Parajuli,
  • Harsh Nitin Dongre,
  • Harsh Nitin Dongre,
  • Borghild Ljøkjel,
  • Kristin Marie Hoven,
  • Arild Kvalheim,
  • Stein Lybak,
  • Evelyn Neppelberg,
  • Evelyn Neppelberg,
  • Dipak Sapkota,
  • Anne Christine Johannessen,
  • Anne Christine Johannessen,
  • Daniela-Elena Costea,
  • Daniela-Elena Costea,
  • Daniela-Elena Costea

DOI
https://doi.org/10.3389/fonc.2022.833582
Journal volume & issue
Vol. 12

Abstract

Read online

BackgroundRecent studies have shown aberrant expression of micro-RNAs in cancer-associated fibroblasts (CAFs). This study aimed to investigate miR-138 dysregulation in CAFs in oral squamous cell carcinoma (OSCC) and its effects on their phenotype and invasion of adjacent OSCC cells.MethodsExpression of miR-138 was first investigated in OSCC lesions (n = 53) and OSCC-derived CAFs (n = 15). MiR-138 mimics and inhibitors were used to functionally investigate the role of miR-138 on CAF phenotype and the resulting change in their ability to support OSCC invasion.ResultsExpression of miR-138 showed marked heterogeneity in both OSCC tissues and cultured fibroblasts. Ectopic miR-138 expression reduced fibroblasts’ motility and collagen contraction ability and suppressed invasion of suprajacent OSCC cells, while its inhibition resulted in the opposite outcome. Transcript and protein examination after modulation of miR-138 expression showed changes in CAF phenotype-specific molecules, focal adhesion kinase axis, and TGFβ1 signaling pathway.ConclusionsDespite its heterogeneous expression, miR-138 in OSCC-derived CAFs exhibits a tumor-suppressive function.

Keywords